MICRO-X LIMITED — AGM Information 2020

Nov 17, 2020

==> picture [175 x 35] intentionally omitted <==

ACN 153 273 735 ASX: MX1

==> picture [19 x 12] intentionally omitted <==

----- Start of picture text -----

Ltd
----- End of picture text -----

ACN 153 273 735 ~~ASX: MX1~~ ACN 153 273 735 ASX: MX1 2020 Annual General Meeting

10.00am (Adelaide time) Virtual Conference 15[th] 15 April 2020[th] April 2020 Peter Rowland Peter Rowland Managing Director & CEO Ma aging Director & CEO 18 November 2020

1

18/11/2020

Agenda

• Open Meeting

• Chairman’s address

• AGM Resolutions

• CEO’s Presentation

• Tube Manufacturing Facility Virtual Tour

• Question and Answer

• Close Meeting

Conference

Annual General Meeting will be held virtually on the online platform, Zoom webinar at

https://us02web.zoom.us/webinar/register/WN_Juna6n0RR76 S8ll9bG1b7g

Voting

Voting to be conducted via web.lumiagm.com/377426520

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Chairman’s Address

© Micro-X Ltd – Annual General Meeting - 18 November 2020

3

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Items of Business

• 2020 Financial Statements and Reports

• Resolution 1 – Adoption of Remuneration Report

• Resolution 2 – Re-election of Patrick O’Brien as a Director

• Resolution 3 – Re-election of David Knox as a Director

• Resolution 4 – Ratification of Issue of Placement Shares

• Resolution 5 – Approval of Employee Share Scheme

• Resolution 6 – Approval of Performance and Service Rights to Peter Rowland

• Resolution 7 – Approval of 10% Placement Capacity

© Micro-X Ltd – Annual General Meeting - 18 November 2020

4

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

2020 Financial Statements and Reports

While not a a requirement that shareholders vote in relation to the accounts, we are pleased to answer any questions you may have relating to them.

© Micro-X Ltd – Annual General Meeting - 18 November 2020

5

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 1 – Adoption of Remuneration Report

To consider and, if thought fit, to pass the following resolution as an ordinary resolution:

“ That for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report (included in the Directors' Report) for the financial year ended 30 June 2020 be adopted.

Note: In accordance with the Corporations Act, this resolution is advisory only and does not bind the Company or the Directors of the Company. The Directors will consider the outcome of the vote and comments made by Shareholders on the Remuneration Report at the meeting when reviewing the Company's remuneration policies.

Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”
Resolution 1	103,525,512	440,286	23,620,323	1,206,439*

• Open-Usable Board 499,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

6

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 2 – Re-election of Mr Patrick O’Brien as a Director of the Company

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

“That Mr Patrick O’Brien, being a Director who retires pursuant to the Constitution of the	“That Mr Patrick O’Brien, being a Director who retires pursuant to the Constitution of the	“That Mr Patrick O’Brien, being a Director who retires pursuant to the Constitution of the	“That Mr Patrick O’Brien, being a Director who retires pursuant to the Constitution of the
Company and being eligible for re-election, offers himself for re-election,			is hereby re-elected
	as a	Director of the Company.”
	Votes	Votes Votes “Abstain	Votes
	“For”	“Against” & Excluded”	“Open-Usable”
Resolution 2	126,853,333	67,134 670,654	1,201,439*

• Open-Usable Board 494,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

7

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 3 – Re-election of Mr David Knox as a Director of the Company

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

“ That Mr David Knox, being a Director who was appointed by the Company's directors on 7 April 2020 pursuant to the Constitution of the Company and being eligible for re-election, offers himself for re-election, is hereby re-elected as a Director of the Company.”

Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”
Resolution 3	127,118,982	97,134	375,005	1,201,439*

• Open-Usable Board 494,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

8

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 4 – Ratification of issue of the Placement Shares

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

“ That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of the Placement Shares on the terms and conditions set out in the Explanatory Statement.”

Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”
Resolution 4	76,820,092	131,379	50,639,650	1,201,439*

• Open-Usable Board 494,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

9

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 5 – Approval of Employee Incentive Plan

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

“ That, for the purposes of ASX Listing Rule 7.2 (Exception 13) and for all other purposes, Shareholders approve the Employee Equity Plan and Employee Gift Plan (together, the Employee Incentive Plan), and the grant of Incentive Securities and the issue of underlying securities under the Employee Incentive Plan, on the terms and conditions set out in the Explanatory Statement.”

Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”
Resolution 5	103,747,383	2,035,928	21,829,810	1,179,439*

• Open-Usable Board 472,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

10

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 6 – Approval of issue of Performance Rights and Service Rights to Mr Peter Rowland under the Employee Equity Plan

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

“That, for the purposes of ASX Listing Rule 10.14, sections 200B and 200E of the Corporations	“That, for the purposes of ASX Listing Rule 10.14, sections 200B and 200E of the Corporations	“That, for the purposes of ASX Listing Rule 10.14, sections 200B and 200E of the Corporations
Act and for all	other purposes, Shareholders approve the issue of Performance Rights and
Service Rights	to Mr Peter Rowland (or his nominee) under the Employee Equity Plan on the
	terms and conditions set out in the Explanatory Statement.”
	Votes Votes Votes “Abstain	Votes
	“For” “Against” & Excluded”	“Open-Usable”
Resolution 6	112,623,662 1,302,154 13,687,305	1,179,439*

• Open-Usable Board 472,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

11

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

RESOLUTION 7 – Approval of 10% Placement Capacity

To consider and, if thought fit, pass the following resolution as an ordinary resolution:

“ That, pursuant to and in accordance with ASX Listing Rule 7.1A and for all other purposes, Shareholders approve the issue of Equity Securities up to 10% of the issued capital of the Company (at the time of the issue) calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2, over a 12 month period from the date of the Annual General Meeting, at a price not less than that determined pursuant to ASX Listing Rule 7.1A.3 and on the terms and conditions set out in the Explanatory Statement accompanying this Notice of Annual General Meeting.”

Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”	Votes “For” Votes “Against” Votes “Abstain & Excluded” Votes “Open-Usable”
Resolution 7	94,846,631	32,216,321	468,169	1,261,439*

• Open-Usable Board 554,294 Open-Usable Non-Board 707,145

© Micro-X Ltd – Annual General Meeting - 18 November 2020

12

Agenda

• Open Meeting

• Chairman’s address

• AGM Resolutions

• CEO’s Presentation

• Tube Manufacturing Facility Virtual Tour

• Question and Answer

• Close Meeting

Conference

Annual General Meeting will be held virtually on the online platform, Zoom webinar at

https://us02web.zoom.us/webinar/register/WN_Juna6n0RR76 S8ll9bG1b7g

Voting

Voting to be conducted via web.lumiagm.com/377426520

==> picture [175 x 35] intentionally omitted <==

ACN 153 273 735 ASX: MX1

==> picture [377 x 391] intentionally omitted <==

----- Start of picture text -----

LtdLtd
To Update with new
graphics
14
----- End of picture text -----

ACN 153 273 735 ~~ASX: MX1~~ ACN 153 273 735 ASX: MX1 CEO Presentation CEO PresentationCompany Presentation Building sales of next generation x-ray Funding strategic growth initiatives to drive sales Fast becoming a commercial success

18th November 201915[th] April 2020

Peter RowlandPeter Rowland 18 November 2020ManagiMa n g Director & CEOaging Director & CEO

Peter Rowland, Managing Director & CEO

© Micro-X Ltd – Annual General Meeting - 18 November 202018/11/2020

Disclaimer

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

SCOPE & LIMITATIONS

This Presentation has been prepared by Micro-X Limited ( Micro-X or the Company ) (ASX.MX1). The Presentation is a summary only and does not contain all the information about the Company’s assets and liabilities, financial position and performance, profits and losses and prospects. This material in this Presentation may be supplemented with an oral presentation and/or other more detailed documents and should not be taken out of context. Although the information contained herein is based upon generally available information and has been obtained from third-party sources believed to be reliable, the Company does not guarantee its accuracy, and such information may be incomplete or condensed. The Company also refers to its filings made with the ASX Limited and the Australian Securities & Investments Commission.

FORWARD LOOKING INFORMATION

This Presentation contains forward looking and other subjective information. Such expectations, estimates, projections and in formation are not a guarantee of future performance and involve unknown risks and uncertainties. Actual results and developments will almost certainly differ from those expressed or implied and recipients of this Presentation should make their own assessment of the expectations, estimates, projections and the relevant assumptions and calculations upon which the opinions, estimates and projections are based. No representation or warranty, express or implied, is given as to the accuracy or completeness of the information or opinions contained in this Presentation and no liability whatsoever is accepted by the Company, or its directors, members, officers, employees, agents or advisers for any use or, or reliance placed upon, such information or opinions.

NOT AN OFFER FOR SECURITIES

This Presentation is not a prospectus, product disclosure statement or other offering document under Australian law (and will not be lodged with ASIC) or any other law. This Presentation does not constitute an offer, invitation, solicitation or recommendation with respect to the purchase or sale of any shares nor does it constitute financial product or investment advice nor take into account your investment objectives, taxation situation, financial situation or needs. An investor must not act on the basis of any matter contained in this Presentation but must make its own assessment of the Company and conduct its own investigations and analysis. Before making an investment in the Company, a prospective investor should consider whether such an investment is appropriate to their particular investment objectives and financial situation and seek appropriate advice, including legal, taxation and financial advice appropriate to their jurisdiction and circumstances.

UNITED STATES

The Company’s securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act ), or under the securities laws of any state or other jurisdiction of the United States. Accordingly, the Company’s securities may not be offered or sold, directly or indirectly, within the United States or to, or for the account of benefit of, U.S. Persons (as defined in Regulation S under the Securities Act as amended). This Presentation may not be distributed within the United States or to any person in the United States

OTHER JURISDICTIONS

This Presentation may only be accessed in other jurisdictions where it is legal to do so.

15

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Key Achievements for FY2020

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Micro-X is now in the commercialisation phase of its globally unique x-ray technology with increased product sales and expanded production capacity

==> picture [36 x 35] intentionally omitted <==

Demonstrated growth in Further insourcing of sales penetration: $3.8M proprietary technology – into international markets High Voltage Generators

==> picture [36 x 35] intentionally omitted <==

Advanced tube manufacturing facility commissioned and further investment in facility

==> picture [36 x 35] intentionally omitted <==

Patent granted for our in-house CNT emitter

Won second contract for Selected by TSA to design UK Government ‘Future Next Generation Aviation Security Solutions’ Checkpoint for US Airports

==> picture [37 x 35] intentionally omitted <==

==> picture [36 x 35] intentionally omitted <==

Achieved US regulatory clearance for Rover

==> picture [37 x 35] intentionally omitted <==

Significant deepening in Strengthened Balance Board and Management Sheet with commercial expertise $30M capital raised

16

© Micro-X Ltd – Annual General Meeting - 18 November 2020

State-of-the-art, tube manufacturing facility

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

A video tour of our x-ray tube manufacturing facility is available on our website

© Micro-X Ltd – Annual General Meeting - 18 November 2020

17

Technology Status

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Growing acceptance that Cold-Cathode is the future of X-Ray

01

Micro-X is first to market with a proven, Cold Cathode, Medical X-Ray product

The goal is attractive, others are attempting to follow :

• Nanox in Israel

02

Proven performance, reliability and lifetime of patented technology in production in Adelaide

• VEC Imaging in Germany with Varex in USA

• Meidensha in Japan

We will have competitors - How long have we got?

03

No more hot filaments – the Edison light bulb becomes solid-state LED

• Getting high current (> 5mA) from the emitter is the first challenge

• Learning how to operate it in an x-ray tube is even harder

04

Huge opportunities for new products with this technology

Based on our experience, we probably have a five-year lead

• This drives the pace of our commercialisation

18

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Our Strategy

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Monetise our ‘ First Mover ’ advantage

Commercialise high in the value chain to maximise revenue – avoid commoditisation as long as possible – keep innovating to stay in front of competitors

Look for the ‘low hanging fruit ’ products where our technology delivers the most customer benefit and thus the best product margins

Successful first movers in breakthrough technology move quickly: 1st early commercial domination becomes a barrier to entry for others

Expand channel partners & collaborations in order to create required paths to market at scale

Our Goal is for Micro-X to have four production lines for four global, high-volume, highmargin products operating : within five years

• Mobile DR (Nano, Rover, et al)

• Backscatter imager for IEDs

• Airport self-service checkpoint

• CT Brain Scanner (in-ambulance stroke diagnosis)

19

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Mobile DR: Nano Mobile X-ray for Healthcare Approved for sale in 40 countries – significant COVID-19 related sales demand $3.8m purchase orders in FY 2020

Bedside imaging – hospitals & temporary facilities

Small & portable – 95kg compared to 350-600kg Approvals – FDA, CE Mark and TGA Installations in global markets ~ 14 countries already Proven reliability + Positive customer feedback Addressable market ~ US$500 million per annum - Orders growing $3.8m in FY2020

==> picture [299 x 242] intentionally omitted <==

Above: Nano being used in The Alfred Hospital, Melbourne

© Micro-X Ltd – Annual General Meeting - 18 November 2020

20

Mobile DR: Rover for Military & Remote Users

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Strong military interest responding to their unmet need – FDA approved $1.4m Sales via WHO in Oct 2020

==> picture [25 x 25] intentionally omitted <==

Rover is an adapted version of the Nano for the military

• Deployed medical facilities treat injured military personnel

• Higher power for trauma use in development

• For use in combat support, disaster relief & humanitarian aid

Unmet need – military currently using small-animal vet X-ray

Limited competition - means higher potential gross margins Achieved FDA Approval - seeking CE mark and TGA approvals Selected for ADF contract for new deployable hospital Addressable market in NATO countries ~US$170M

==> picture [246 x 279] intentionally omitted <==

Above: Rover testing in deployed hospital setting

21

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Mobile DR: Expanding Rover Markets

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

The extreme mobility and low weight of Rover opens up possible new uses

==> picture [39 x 27] intentionally omitted <==

==> picture [39 x 37] intentionally omitted <==

Point-of-Care x-ray imaging

• Avoiding x-ray outpatient dept in hospitals

• Door-to-door x-ray service with tele-radiology

• Aged-care homes

• Home visits

Small-animal veterinary hospitals

• Increasingly upgrading from film to digital imaging

• Improve workflow & productivity

• Reduced regulatory environment

==> picture [192 x 168] intentionally omitted <==

==> picture [195 x 198] intentionally omitted <==

22

© Micro-X Ltd – Annual General Meeting - 18 November 2020

IED Imaging Camera

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Backscatter X-Ray Assessment of IEDs via robot

==> picture [170 x 140] intentionally omitted <==

• X-Ray ‘Camera’ takes images without separate detector– one sided viewing

• Bomb disposal technicians face life threatening situation when placing conventional X-ray detector behind target

• Australian Defence Force proof of concept imaging test completed

Illustration of MBI in action

==> picture [219 x 185] intentionally omitted <==

• Customer interest from military and FBI / bomb disposal technicians

• No competition = high gross margins

• Addressable market ~US$1.8B

23

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Breaking News : Imaging test success

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

New Backscatter Imaging Approach confirmed for project - new architecture for IED Camera

==> picture [218 x 228] intentionally omitted <==

10 second image Explosive material easily visible inside backpack

==> picture [225 x 228] intentionally omitted <==

60 second image High Resolution Scan

==> picture [175 x 233] intentionally omitted <==

Resolving easily:

• Thin red wires 0.32mm diameter

• Electronic circuits

Bomb/No Bomb Assessment

Detailed Threat Assessment

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Breaking News: Major architecture change now adopted

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

New Backscatter Imaging Approach – smaller , lighter , and faster with higher resolution , larger field-of-view , configurable design, faster to market , and lower development risk . New product COGS is 30% of previous

==> picture [186 x 149] intentionally omitted <==

==> picture [118 x 94] intentionally omitted <==

Feature	Previous Configuration	New Configuration
Dimensions of System	43.5cm x 43.5cm x 54cm	34cm x 34cm x 47cm
Weight	36kg	22kg
Field of View	18cm x 18cm	40cm x 40cm
Resolution	0.5mm	0.33mm
Imaging Speed	30 second (low resolution) 180 second (high resolution)	10 second (low resolution) 60 second (high resolution)
Time to Market	30 months	12 months
Development Risk	High	Low

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Airport Self-service Checkpoint

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

TSA funded ‘Checkpoint of the Future’

==> picture [31 x 31] intentionally omitted <==

Airport Checkpoint security

A blend of backscatter and transmission X-ray to provide three dimensional imaging of carry on luggage Integrated body scanner and passport reader

Based on work Micro-X is undertaking with the UK Government’s Department for Transportation

Concept reimagines the future of airport checkpoints based on self-service model

Addressable global market ~US$24B TSA alone US$8B market opportunity

==> picture [255 x 304] intentionally omitted <==

Above: Illustration of Future Airport Checkpoint Portal

26

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Brain imaging for strokes

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Point-of-care diagnosis inside the Golden Hour

Brain Tomography for Stroke diagnosis

New medical imaging technology for pre-hospital diagnosis of strokes in a mobile setting such as a road or air ambulance

Curved detector will be the first of its kind and be built in collaboration with Fujifilm

Awaiting confirmation of potential $15m funding under Second Phase of the Australian Stroke Alliances Project

==> picture [211 x 213] intentionally omitted <==

==> picture [27 x 27] intentionally omitted <==

==> picture [353 x 172] intentionally omitted <==

Potential to be a game changer in modern stroke treatment with addressable market ~US$5B

27

Illustration of curved ring scanner in ambulance setting

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Established Capability: Manufacturing Operations

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

World-class manufacturing with efficiency learned from the automotive industry

• State of the art manufacturing facility spanning over 2,000m[2]

• South Australian Tonsley Innovation District

• ISO 13485 certified Quality Management System

• $4 million invested since April 2020

• Capacity now 2 units (Nano/Rover) per day

• Component inventory supports Nano or Rover product

• Local supply chain – heading towards 95% Australian with huge reduction in cycle time

==> picture [247 x 164] intentionally omitted <==

Above: Assembly of Rover units prior to shipment

• Nano and Rover build on same line with 95% parts commonality

==> picture [169 x 83] intentionally omitted <==

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Established Capability: Engineering Design

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

World-class capability in multi-disciplinary systems design

• Customer-led design methodology; proven fast track development process

• ISO13485 accredited design processes

• 23 engineers and scientists covering: Mechanical & Materials; Electronics & Control; Software & Systems; Vacuum physics; High Voltage engineering; Ergonomics & workflow

• Centre of Excellence in software & Image processing to be established in Micro-X Inc. in Seattle WA

• 2 key patents granted this year

• In-house, proprietary, image re-construction software algorithms for 3D backscatter and transmission

• TSA contract award recognises systems design, project management & prime contracting capability - not just CNT technology

==> picture [225 x 300] intentionally omitted <==

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Platform Technologies: Next Gen CNT X-ray

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Summit: Next generation mini-tube for multi-source applications – designed for mass production

NUGGET

MOSAIC

Specification Value Voltage Range 40kV – 110kV Current Range 30mA – 70mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5 Specification Value Voltage Range 40kV – 120kV Current Range 30mA – 100mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5	Specification Value Voltage Range 40kV – 110kV Current Range 30mA – 70mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5 Specification Value Voltage Range 40kV – 120kV Current Range 30mA – 100mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5	Specification Value Voltage Range 40kV – 110kV Current Range 30mA – 70mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5 Specification Value Voltage Range 40kV – 120kV Current Range 30mA – 100mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5	Specification Value Voltage Range 40kV – 110kV Current Range 30mA – 70mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5 Specification Value Voltage Range 40kV – 120kV Current Range 30mA – 100mA Size (cm) 16.3 x 11 x 10 Weight (kg) 1.5
Specification	Value	Specification	Value
Voltage Range	40kV – 110kV	Voltage Range	40kV – 120kV
Current Range	30mA – 70mA	Current Range	30mA – 100mA
Size (cm)	16.3 x 11 x 10	Size (cm)	16.3 x 11 x 10
Weight (kg)	1.5	Weight (kg)	1.5

FUGGLES SUMMIT

==> picture [47 x 91] intentionally omitted <==

==> picture [160 x 64] intentionally omitted <==

Specification	Value		Specification	Value
Voltage Range	160kV		Voltage Range	60kV-120kV
Current Range	1mA		Current Range	60mA
Size (cm)			Size (cm)	8.2 x 3.8 x 4.2
Weight (kg)	0.5		Weight (kg)	0.5

Our first in-house X-ray tube for NANO

High Power X-ray tube for ROVER

Integrated Tube and Generator for MBI

Next Generation Mini-Tube

• Mass production for multi-source gantry applications:

• Airport Security

• o Brain CT

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Platform Technologies: Image Processing

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Image Reconstruction & Processing

==> picture [100 x 108] intentionally omitted <==

==> picture [101 x 108] intentionally omitted <==

==> picture [106 x 107] intentionally omitted <==

==> picture [214 x 121] intentionally omitted <==

==> picture [85 x 261] intentionally omitted <==

Backscatter Image Reconstruction and Display

==> picture [311 x 111] intentionally omitted <==

Core Property Imaging Software and Algorithms

• Platform Imaging software leveraging unique properties of CNT x-ray tubes

Stroke Tomosynthesis Reconstruction and Display

• Combines conventional x-ray 3D imaging with unique backscatter imaging

==> picture [311 x 110] intentionally omitted <==

• Developed in-house during MRFF phase 1 grant, UK DFT grant, and MBI development

• Continue to develop in TSA funded program

Explosives Imaging CT Reconstruction and Detection

31

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Platform Technologies: High Voltage Supplies

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

In-house High Power generator project – central to all future x-ray tubes

Objective : Complete in-house design & manufacture of high power generator by mid 2021 - reduce manufacturing costs and enable high-power Rover product for sale

Design work for in-house generator largely completed

Project investment is $3.5m over 10 months

• Build samples, test, certify and develop manufacturing infrastructure

• $1.6m in materials and Capex; $1.9m on engineering services

Production of generators targeted by end of 1Q 2021

• Enable control of supply chain and reduced manufacturing costs

==> picture [157 x 163] intentionally omitted <==

Illustration of High Powered 120kV Generator

• Platform technology for all future products

==> picture [224 x 90] intentionally omitted <==

Monoblock 160kV

==> picture [203 x 107] intentionally omitted <==

==> picture [136 x 104] intentionally omitted <==

Bi-Polar hand held Monoblock 100kV

Multi-Source high voltage switching for MBS/Brain Tomo

32

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Our Four Production Lines

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Micro-X has a strategically planned product roll-out as our CNT technology is advanced

Product		First sales		Addressable Market
Mobile Bedside DR Backscatter Counter-IED Airport Checkpoint Stroke Brain Scanner 2018 2022 2024 2026 US$670M p.a. US$1.8B USA: US$8B RoW: US$16B US$5B*

• These dates are estimates and may vary

33

© Micro-X Ltd – Annual General Meeting - 18 November 2020

Conclusion

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Unlocking value from our revolutionary CNT technology

• Own the proven technical edge

• Products in market – with revenue

• Multiple product lines in design

• Massive addressable markets

• Customer pull – not technology push

• Demonstrated design & manufacturing capability to deliver

• Continuous innovation to drive value

34

© Micro-X Ltd – Annual General Meeting - 18 November 2020

==> picture [236 x 44] intentionally omitted <==

Ltd

ACN 153 273 735

Peter Rowland Managing Director 1284 South Road Tonsley SA 5042 +61 8 7099 3966 or +61 418 844 981 admin@micro-x.com micro-x.com

Ordinary Business

==> picture [100 x 19] intentionally omitted <==

==> picture [624 x 6] intentionally omitted <==

Question Time Voting to Close

Conclusion of Formal Business

© Micro-X Ltd – Annual General Meeting - 18 November 2020

36